![[LSBNL] Life-Sciences-Benelux.com - The Benelux Life Sciences Web Portal](/images/basics/lsbnl-life-sciences-benelux-portal-logo.svg){kind=logo}
Advertisement
Products > All
Find below all kinds of products and services from companies in the Benelux countries or related to them.Total search results: 1294 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 
  Product |
Product Group |
Organisation |
 Date |
|---|---|---|---|
| PancAlert pancreatic cancer screening test | cancer test | Mainz Biomed N.V. (Nasdaq: MYNZ) | 2024-09-04 |
| Centogene Biodatabank | genomic database | Centogene (Group) | 2024-08-07 |
| Intelligent Architecture™ platform | industrial enzyme | Biomatter Designs (LT) | 2024-08-05 |
| TCR:CO-STIM platform | T cell therapy | Pan Cancer T B.V. | 2024-07-11 |
| Vesalius Biocapital IV | fund, human health | Vesalius Biocapital (Group) | 2024-07-10 |
| Forbion BioEconomy Fund I | fund, human health | Forbion (Group) | 2024-06-20 |
| PINK! Coach | disease/treatment management software | Sidekick Health (Group) | 2024-06-18 |
| AIM™ technology (Annogen) | genomic technology | 2024-06-04 | |
| OmciSoft Land Databases | biological/chemical database_o | Qiagen (Group) | 2024-06-03 |
| EVA™ smart robotic drug discovery platform | drug discovery technology_o | LabGenius Ltd. | 2024-05-22 |
| BiCE™ platform (Bispecific Complement Engaging platform) | drug development technology | 2024-05-09 | |
| MiXCR software platform | genomic software tools | 2024-04-29 | |
| European Patient Observatory (HTFC) | healthcare_oo | HealthTech For Care (HTFC) (endowment fund launched by FranceBiotech) | 2024-04-03 |
| Antibody-Extractor platform (AbnomX) | drug discovery software | AbnomX (BE) | 2024-04-02 |
| Accelerator Mass Spectrometry (AMS technology) | mass spectrometry (MS) | 2024-03-25 | |
| DDX platform (Dually Derivatized Oligochitosan platform) | gene therapy technology | EnGene (Group) | 2024-02-14 |
| EG-70 (genetic medicine, EnGene) | biopharmaceutical_o | EnGene (Group) | 2024-02-14 |
| Clear-X™ linker technology | RADIOPHARMACEUTICAL (RPT) | Full-Life Technologies (Group) | 2024-01-04 |
| Res-X™ modification methods | RADIOPHARMACEUTICAL (RPT) | Full-Life Technologies (Group) | 2024-01-04 |
| Katana iPS-T cell therapy paltform (CD8aß iPS-T cell platform) | T cell therapy | 2023-12-12 | |
| ConformalFLASH® technology | proton therapy | 2023-12-05 | |
| Writefull AI-based academic language service | artificial intelligence_o | Holtzbrinck (Group) | 2023-11-21 |
| polyNaut® drug delivery platform | drug delivery technology_o | ViaNautis Bio Ltd. | 2023-11-13 |
| vivoXPRESS® manufacturing platform | biopharmaceutical production technology (biomanufacturing) | PlantForm Corporation (CA) | 2023-11-13 |
| BioMx software | data integration and analysis software (bioinformatics) | BioLizard (Group) | 2023-10-11 |
| BioReflect software | data integration and analysis software (bioinformatics) | BioLizard (Group) | 2023-10-11 |
| ProBiome software | data integration and analysis software (bioinformatics) | BioLizard (Group) | 2023-10-11 |
| ColoAlert® colorectal cancer screening test | cancer test | Mainz Biomed N.V. (Nasdaq: MYNZ) | 2023-09-20 |
| Ayvakit® | tyrosine kinase inhibitor (TKI) | Blueprint Medicines (Group) | 2023-08-07 |
| therascreen® PDGFRA RGQ PCR kit | clinical genomic test (nucleic acid diagnostics) | Qiagen (Group) | 2023-08-07 |
| Tami digital patient companion app (Temedica / AbbVie) | digital health app | AbbVie (Group) | 2023-08-02 |
| HUB Organoid Technology | 3D cell culture technology (organoid technology) | HUB Organoids (NL) | 2023-07-18 |
| Vyvgart® Hytrulo | therapeutic antibody | Argenx (Argen-X) (Group) | 2023-07-17 |
| BioGeneration Ventures V fund (BGV V) | fund, human health | BioGeneration Ventures B.V. (BGV) | 2023-07-13 |
| Lakhesys™ platform | advanced therapeutic product (gene therapy, cell therapy, tissue engineering products) | Astraveus SAS | 2023-06-27 |
| SonoCloud® system | drug delivery technology_o | Carthera (Group) | 2023-06-27 |
| NLC Health Impact Fund | fund, human health_o | NLC Ventures (Group) | 2023-06-26 |
| THE001 (DPPG2-TSL-DOX; thermosensitive liposomal formulation of doxorubicin) | anthracycline | Thermosome GmbH | 2023-06-20 |
| Qiagen Clinical Insight Interpret software (QCI Interpret) | genomic software tools | Qiagen (Group) | 2023-06-13 |
| ColoNode® IVD gene expression signature test for colorectal cancer | cancer test | HiloProbe AB | 2023-05-09 |
| Forbion Ventures Fund VI | fund, human health | Forbion (Group) | 2023-04-19 |
| Gilde Healthcare Venture&Growth VI fund | fund, human health_o | Gilde Investment (Group) | 2023-04-19 |
| APIS Breast Cancer Subtyping Kit | cancer test | APIS Assay Technologies (Group) | 2023-04-04 |
| APIS Precision Expression Assay | diagnostic test | APIS Assay Technologies (Group) | 2023-04-04 |
| APIS SARS-CoV-2 IgG ELISA Kit | clinical test_other | APIS Assay Technologies (Group) | 2023-04-04 |
| APIS SARS-CoV-2 IgG ELONA Kit | clinical test_other | APIS Assay Technologies (Group) | 2023-04-04 |
| Clickmers (ligand binding technology) | drug development technology | APIS Assay Technologies (Group) | 2023-04-04 |
| Gohibic | therapeutic antibody | InflaRx (Group) | 2023-04-04 |
| SydLab™ One platform | organ-on-a-chip product_o | Nagi Bioscience S.A. | 2023-03-29 |
| Newcycling® process | industrial biotechnology_o | 2023-02-08 | |
| superRCA technology (for mutation detection from liquid biopsies) | molecular diagnostics | 2023-02-06 | |
| DO-2 (DeuterOncology / Octimet Oncology / Janssen Pharmaceutica) | tyrosine kinase inhibitor (TKI) | DeuterOncology N.V. | 2023-01-19 |
| Concentriq® Dx digital pathology platform | pathology | Proscia Inc. | 2023-01-18 |
| EZ2 Connect MDx platform | automated sample preparation technology_o | Qiagen (Group) | 2023-01-17 |
| PhageDiag (diagnostic phagogram using AI for personalized phage therapy) | diagnostic technology_o | Vesalius Biocapital (Group) | 2023-01-17 |
| GEDmatch database and GEDmatch PRO™ portal | genomic database | Qiagen (Group) | 2023-01-09 |
| MiSeq FGx® Sequencing System | DNA sequencing system_other | Illumina (Group) | 2023-01-09 |
| Hemgenix® | gene therapy hemophilia B | CSL (Group) | 2022-11-22 |
| A-Kine™ platform | drug discovery technology_o | Orionis Biosciences (Group) | 2022-10-19 |
| PPI-FIT approach (Pharmacological Protein Inactivation by Folding Intermediate Targeting approach) | drug development technology | Sibylla Biotech S.p.A. | 2022-10-04 |
| Topaz transfemoral tricuspid heart valve replacement system | valve (medical) | Tricares (Group) | 2022-09-15 |
| Aido endoscopy control system | endoscopy_o | Aido (FR) | 2022-09-08 |
| Fermotein® | food ingredient | The Protein Brewery B.V. (TPB) | 2022-09-01 |
| Cimerli™ (FYB201, ranibizumab biosimilar) | ophthalmic_o | Formycon (Group) | 2022-08-03 |
| Haermonics Pure™ therapy (flush therapy device) | MedTech (medical technology)_oo | Haermonics B.V. | 2022-08-02 |
| Oncotype DX® GPS (Genomic Prostate Score®) | clinical genomic test (nucleic acid diagnostics) | Exact Sciences (Group) | 2022-08-02 |
| Somnia Digital Health Solution | digital health app | ResMed (Group) | 2022-08-02 |
| Forty51 Ventures Fund I SCSp, FIAR | fund, human health | Forty51 Ventures (Group) | 2022-07-18 |
| SHS VI fund | fund, human health_o | SHS Capital (Group) | 2022-07-18 |
| Primariz OEM XYZ-Autosampler | laboratory automation equipment_o | Knauer (Group) | 2022-06-27 |
| Forbion Growth Opportunities Fund II (Forbion Growth II) | fund, human health | Forbion (Group) | 2022-06-09 |
| FramePro platform | drug discovery technology_o | CureVac (Group) | 2022-06-08 |
| ACTallo® platform (allogeneic gamma delta T cell therapy platform) | cell therapy technology | Immatics (Group) | 2022-06-02 |
| TCR/BCR (T Cell Receptor/B Cell Receptor) repertoire profiling | diagnostic technology_o | Eurofins (Group) | 2022-05-31 |
| Mercurius™ Blood BRB-seq | sample preparation, nucleic acid (technology) | Alithea Genomics S.A. | 2022-05-24 |
| Mercurius™ BRB-seq | sample preparation, nucleic acid (technology) | Alithea Genomics S.A. | 2022-05-24 |
| Volta technology (Avantium) | industrial biotechnology_o | Avantium (Group) | 2022-05-17 |
| Vtama® | dermatic_o | Organon (Group) | 2022-05-01 |
| Dawn Technology™ | industrial biotechnology_o | Avantium (Group) | 2022-03-31 |
| Ray Technology™ | industrial biotechnology_o | Avantium (Group) | 2022-03-31 |
| YXY® plant-to-plastics technology | industrial biotechnology_o | Avantium (Group) | 2022-03-31 |
| HYFT™ fingerprints technology | genomic software tools | ImmunoPrecise (Group) | 2022-03-29 |
| Gilde Healthcare Private Equity IV fund (GHPE IV) | fund, human health_o | Gilde Investment (Group) | 2022-03-16 |
| Ella® high-throughput egg screening machine | AGRI LIFE SCIENCES_o | In Ovo B.V. | 2022-03-01 |
| Microlyse | anticoagulant_o | TargED Biopharmaceuticals B.V. | 2022-02-22 |
| protein splicing technology | drug development technology | SpliceBio S.L. | 2022-02-16 |
| Newton Biocapital II (NBC II fund) | fund, human health | Newton Biocapital (NBC) (Group) | 2022-02-15 |
| SureTACsR technology platform | drug development technology | Laigo Bio (NL) | 2022-02-08 |
| Kimmtrak® | cancer immunotherapy (immuno-oncology, I-O) | Immunocore Holdings plc (Nasdaq: IMCR) | 2022-01-26 |
| PanFlu using CR9914 | virostatic agent | Leyden Laboratories (Leyden Labs) (Group) | 2022-01-25 |
| Quadrupole C-Trap® Optical Tweezers – Fluorescence + Label-free Microscopy system | microscope_o | Lumicks (Group) | 2022-01-12 |
| Vyvgart® | therapeutic antibody | Argenx (Argen-X) (Group) | 2021-12-17 |
| Thuja Capital Healthcare Fund III | fund, human health | Thuja Capital (Group) | 2021-12-16 |
| GPSDetect™ software | software_oo | Sirius Medical (Group) | 2021-12-14 |
| UCB0599 (Novartis / UCB / Neuropore Therapies) | Parkinson drug | UCB (Group) | 2021-12-02 |
| UCB7853 (UCB) | therapeutic antibody | UCB (Group) | 2021-12-02 |
| gammy-CUBE preclinical micro-SPECT scanner | PET/CT device | Bruker (Group) | 2021-11-19 |
| X-CUBE preclinical micro-CT scanner | PET/CT device | Bruker (Group) | 2021-11-19 |
| ß-CUBE preclinical micro-PET scanner | PET/CT device | Bruker (Group) | 2021-11-19 |
| LSP 7 fund (Life Sciences Partners) | fund, human health | EQT (Wallenberg family) (Group) | 2021-11-04 |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
